| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.27 |
3e-08 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.23 |
9e-05 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0003 |